"10.1371_journal.pone.0079839","plos one","2013-11-11T00:00:00Z","Wenjuan He; Qionghong Xie; Yingying Wang; Jing Chen; Min Zhao; Linda S Davis; Matthew D Breyer; Guoqiang Gu; Chuan-Ming Hao","Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China; Gladstone Institute of Virology & Immunology, San Francisco, California, United States of America; Nephrology Division, Vanderbilt University Medical Center School of Medicine, Nashville, Tennessee, United States of America; Biotechnology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America; Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America","Conceived and designed the experiments: CMH MDB. Performed the experiments: WH QX YW JC MZ LSD CMH. Analyzed the data: WH MDB CMH. Contributed reagents/materials/analysis tools: GG. Wrote the paper: CMH WH.","Dr. Matt Breyer is currently employed by Eli Lilly, but his involvement to the work in the present manuscript was happened when he was at Vanderbilt University. This therefore does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Wenjuan He","WH",9,TRUE,2,7,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
